Products

Get a quote

We're excited to learn more about your project and provide you with a customized quote tailored to your needs. Please fill out the form below, and we'll get back to you as soon as possible.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Canine Legumain (LGMN) ELISA Kit-Sandwich

Name: Canine Legumain (LGMN) ELISA Kit-Sandwich
SKU: EK10F589
Rating: 5 (1 reviews)

Cat. No.EK10F589

Product TypeAnimal Immunoassay Kits

Size

Inquiry Now Add to Basket

Product Overview

BioVenic Canine LGMN ELISA Kit-Sandwich is designed for the quantitative determination of Canine legumain (LGMN) in serum, plasma, tissue homogenate, cell culture supernatant, cell lysate, and other biological fluids using a Sandwich ELISA method. For research use only.

Specifications

Assay Type ELISA-Sandwich

Specificity The assay kit is specific for Canine LGMN.

Target Species Canine

Species Reactivity Canine

Detection Range 32-2000 pg/mL

Sensitivity 6.25 pg/mL

Reproducibility Intra-Assay: CV < 10%; Inter-Assay: CV < 10%

Assay Time Around 180 min

Sample Requirement Serum, plasma, tissue homogenate, cell culture supernatant, cell lysate, and other biological fluids.

Target Information

Legumain is encoded by the LGMN gene in dogs. It has been demonstrated to be overexpressed not just in breast, prostatic, and liver tumor cells, but also in the macrophages that compose the tumor microenvironment.

Target/Biomarker Canine LGMN

Target Synonym legumain

Gene ID 480232

UniProt ID A0A8I3P903

Shipping and Storage

This product is shipped with gel ice packs. It is recommended to store at 2-8 °C (Up to 6 months).

Documents

Datasheet

COA

To request a Certificate of Analysis, please enter the Lot No. in the search box. Note: Certificate of Analysis not available for kits.

The product is for research use only.
Not for commercial, prophylactic, diagnostic, or therapeutic applications.

References

Khan, S. U. et al. Role of LGMN in tumor development and its progression and connection with the tumor microenvironment. Frontiers in molecular biosciences. 2023, 10: 1121964.